A. N. Ahyi, H. C. Chang, A. L. Dent, S. L. Nutt, and M. H. Kaplan, IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines, J. Immunol, vol.183, pp.1598-1606, 2009.

E. Amiel, B. Everts, T. C. Freitas, I. L. King, J. D. Curtis et al., Inhibition of mechanistic target of rapamycin promotes dendritic cell activation and enhances therapeutic autologous vaccination in mice, J. Immunol, vol.189, pp.2151-2158, 2012.

H. An, H. Xu, M. Zhang, J. Zhou, T. Feng et al., Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity-and PI-3K-independent mechanism, Blood, vol.105, pp.4685-4692, 2005.

O. Ananieva, J. Darragh, C. Johansen, J. M. Carr, J. Mcilrath et al., The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling, Nat. Immunol, vol.9, pp.1028-1036, 2008.

T. T. Antoniv and L. B. Ivashkiv, Interleukin-10-induced gene expression and suppressive function are selectively modulated by the PI3K-Akt-GSK3 pathway, Immunology, vol.132, pp.567-577, 2011.

L. Apetoh, F. J. Quintana, C. Pot, N. Joller, S. Xiao et al., The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27, Nat. Immunol, vol.11, pp.854-861, 2010.

D. Aschenbrenner, M. Foglierini, D. Jarrossay, D. Hu, H. L. Weiner et al., An immunoregulatory and tissue-residency program modulated by c-MAF in human T H 17 cells, Nat. Immunol, vol.19, pp.1126-1136, 2018.

K. Autio and M. Oft, Pegylated Interleukin-10: Clinical Development of an Immunoregulatory Cytokine for Use in Cancer Therapeutics, Curr. Oncol. Rep, vol.21, p.19, 2019.

S. Balaji, X. Wang, A. King, L. D. Le, S. S. Bhattacharya et al., Interleukin-10-mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signaling, 2017.

, FASEB J, vol.31, pp.868-881

V. Balasingam and V. W. Yong, Attenuation of astroglial reactivity by interleukin-10, J. Neurosci, vol.16, pp.2945-2955, 1996.

A. Banerjee, R. Gugasyan, M. Mcmahon, and S. Gerondakis, Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells, Proc. Natl. Acad. Sci. USA, vol.103, pp.3274-3279, 2006.

F. J. Barrat, D. J. Cua, A. Boonstra, D. F. Richards, C. Crain et al., In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines, J. Exp. Med, vol.195, pp.603-616, 2002.

Y. Belkaid, K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey et al., The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure, J. Exp. Med, vol.194, pp.1497-1506, 2001.

R. M. Berman, T. Suzuki, H. Tahara, P. D. Robbins, S. K. Narula et al., Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice, J. Immunol, vol.157, pp.231-238, 1996.

C. Bogdan, Y. Vodovotz, and C. Nathan, Macrophage deactivation by interleukin 10, J. Exp. Med, vol.174, pp.1549-1555, 1991.

P. P. Boor, H. J. Metselaar, S. Mancham, L. J. Van-der-laan, and J. Kwekkeboom, Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions, Clin. Exp. Immunol, vol.174, pp.389-401, 2013.

H. Braat, P. Rottiers, D. W. Hommes, N. Huyghebaert, E. Remaut et al., A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease, Clin. Gastroenterol. Hepatol, vol.4, pp.754-759, 2006.

D. G. Brooks, M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. Mcgavern et al., Interleukin-10 determines viral clearance or persistence in vivo, Nat. Med, vol.12, pp.1301-1309, 2006.

M. D. Buck, D. O'sullivan, and E. L. Pearce, T cell metabolism drives mmunity, J. Exp. Med, vol.212, pp.1345-1360, 2015.

A. R. Burmeister and I. Marriott, The Interleukin-10 Family of Cytokines and Their Role in the CNS, Front. Cell. Neurosci, vol.12, p.458, 2018.

F. E. Buruiana, I. Solà, and P. Alonso-coello, Recombinant human interleukin 10 for induction of remission in Crohn's disease, Cochrane Database Syst. Rev, issue.11, p.5109, 2010.

S. Cao, J. Liu, L. Song, and X. Ma, The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages, J. Immunol, vol.174, pp.3484-3492, 2005.

W. Cao, S. Manicassamy, H. Tang, S. P. Kasturi, A. Pirani et al., Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycinsensitive PI(3)K-mTOR-p70S6K pathway, Nat. Immunol, vol.9, pp.1157-1164, 2008.

A. Cardoso, A. Castro, A. C. Martins, G. M. Carriche, V. Murigneux et al., The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis, Front. Immunol, vol.9, p.400, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01737190

M. A. Cassatella, L. Meda, S. Bonora, M. Ceska, and G. Constantin, Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide, J. Exp. Med, vol.178, pp.2207-2211, 1993.

A. Chakrabarti, A. J. Sadler, N. Kar, H. A. Young, R. H. Silverman et al., Protein kinase R-dependent regulation of interleukin-10 in response to double-stranded RNA, J. Biol. Chem, vol.283, pp.25132-25139, 2008.

C. S. Chan, A. Ming-lum, G. B. Golds, S. J. Lee, R. J. Anderson et al., Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor-? translation through a SHIP1-dependent pathway, J. Biol. Chem, vol.287, pp.38020-38027, 2012.

E. Y. Chang, B. Guo, S. E. Doyle, and G. Cheng, Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production, J. Immunol, vol.178, pp.6705-6709, 2007.

H. D. Chang, C. Helbig, L. Tykocinski, S. Kreher, J. Koeck et al., Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3, Eur. J. Immunol, vol.37, pp.807-817, 2007.

A. Chaudhry, R. M. Samstein, P. Treuting, Y. Liang, M. C. Pils et al., Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation, Immunity, vol.34, pp.566-578, 2011.

Q. Chen, V. Daniel, D. W. Maher, and P. Hersey, Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma, Int. J. Cancer, vol.56, pp.755-760, 1994.

H. Chi, S. P. Barry, R. J. Roth, J. J. Wu, E. A. Jones et al., Dynamic regulation of pro-and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses, 2006.

, Proc. Natl. Acad. Sci. USA, vol.103, pp.2274-2279

M. Ciofani, A. Madar, C. Galan, M. Sellars, K. Mace et al., A validated regulatory network for Th17 cell specification, Cell, vol.151, pp.289-303, 2012.

S. P. Colgan, R. M. Hershberg, G. T. Furuta, and R. S. Blumberg, Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling, Proc. Natl. Acad. Sci. USA, vol.96, pp.13938-13943, 1999.

J. F. Colombel, P. Rutgeerts, H. Malchow, M. Jacyna, O. H. Nielsen et al., Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease, Gut, vol.49, pp.42-46, 2001.

E. A. Conaway, D. C. De-oliveira, C. M. Mcinnis, S. B. Snapper, and B. H. Horwitz, Inhibition of Inflammatory Gene Transcription by IL-10 Is Associated with Rapid Suppression of Lipopolysaccharide-Induced Enhancer Activation, J. Immunol, vol.198, pp.2906-2915, 2017.

S. M. Coomes, Y. Kannan, V. S. Pelly, L. J. Entwistle, R. Guidi et al., CD4 + Th2 cells are directly regulated by IL-10 during allergic airway inflammation, Mucosal Immunol, vol.10, pp.150-161, 2017.

K. N. Couper, D. G. Blount, and E. M. Riley, IL-10: the master regulator of immunity to infection, J. Immunol, vol.180, p.5771, 2008.

J. B. Crawley, L. M. Williams, T. Mander, F. M. Brennan, and B. M. Foxwell, Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine, J. Biol. Chem, vol.271, pp.16357-16362, 1996.

W. D. Creery, F. Diaz-mitoma, L. Filion, and A. Kumar, Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype, Eur. J. Immunol, vol.26, pp.1273-1277, 1996.

B. A. Croker, D. L. Krebs, J. G. Zhang, S. Wormald, T. A. Willson et al., SOCS3 negatively regulates IL-6 signaling in vivo, Nat. Immunol, vol.4, pp.540-545, 2003.

F. Q. Cunha, S. Moncada, and F. Y. Liew, Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages, Biochem. Biophys. Res. Commun, vol.182, pp.1155-1159, 1992.

A. D'andrea, M. Aste-amezaga, N. M. Valiante, X. Ma, M. Kubin et al., Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells, J. Exp. Med, vol.178, pp.1041-1048, 1993.

W. J. Dai, G. Köhler, and F. Brombacher, Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice, J. Immunol, vol.158, pp.2259-2267, 1997.

C. Danne, G. Ryzhakov, M. Martínez-lópez, N. E. Ilott, F. Franchini et al., A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Antiinflammatory Gene Signature in Macrophages, Cell Host Microbe, vol.22, pp.733-745, 2017.

M. A. Den-boer, P. J. Voshol, J. P. Schröder-van-der-elst, E. Korsheninnikova, D. M. Ouwens et al., Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice. Endocrinology, vol.147, pp.4553-4558, 2006.

R. De-waal-malefyt, J. Abrams, B. Bennett, C. G. Figdor, and J. E. De-vries, Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes, J. Exp. Med, vol.174, pp.1209-1220, 1991.

R. De-waal-malefyt, J. Haanen, H. Spits, M. G. Roncarolo, A. Velde et al., Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression, J. Exp. Med, vol.174, pp.915-924, 1991.

L. Ding and E. M. Shevach, IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function, J. Immunol, vol.148, pp.3133-3139, 1992.

R. P. Donnelly, H. Dickensheets, and D. S. Finbloom, The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes, J. Interferon Cytokine Res, vol.19, pp.563-573, 1999.

G. P. Dunn, L. J. Old, and R. D. Schreiber, The immunobiology of cancer immunosurveillance and immunoediting, Immunity, vol.21, pp.137-148, 2004.

K. C. El-kasmi, A. M. Smith, L. Williams, G. Neale, A. D. Panopoulos et al., Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway, J. Immunol, vol.179, pp.7215-7219, 2007.

D. Ellinghaus, L. Jostins, S. L. Spain, A. Cortes, J. Bethune et al., Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci, Nat. Genet, vol.48, pp.510-518, 2016.

J. Emmerich, J. B. Mumm, I. H. Chan, D. Laface, H. Truong et al., IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs, Cancer Res, vol.72, pp.3570-3581, 2012.

K. R. Engelhardt and B. Grimbacher, IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms, Curr. Top. Microbiol. Immunol, vol.380, pp.1-18, 2014.

K. A. Fairfax, M. P. Gantier, F. Mackay, B. R. Williams, and C. E. Mccoy, IL-10 regulates Aicda expression through miR-155, J. Leukoc. Biol, vol.97, pp.71-78, 2015.

R. N. Fedorak, A. Gangl, C. O. Elson, P. Rutgeerts, S. Schreiber et al., Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group, Gastroenterology, vol.119, pp.1473-1482, 2000.

D. F. Fiorentino, M. W. Bond, and T. R. Mosmann, Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones, J. Exp. Med, vol.170, pp.2081-2095, 1989.

D. F. Fiorentino, A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'garra, IL-10 inhibits cytokine production by activated macrophages, J. Immunol, vol.147, pp.3815-3822, 1991.

D. F. Fiorentino, A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard et al., IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells, J. Immunol, vol.146, pp.3444-3451, 1991.

S. B. Fleming, C. A. Mccaughan, A. E. Andrews, A. D. Nash, and A. A. Mercer, A homolog of interleukin-10 is encoded by the poxvirus orf virus, J. Virol, vol.71, pp.4857-4861, 1997.

K. Frei, D. Nadal, H. W. Pfister, and A. Fontana, Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10, J. Exp. Med, vol.178, pp.1255-1261, 1993.

L. Gabry?ová, A. Howes, M. Saraiva, and A. O'garra, The regulation of IL-10 expression, Curr. Top. Microbiol. Immunol, vol.380, pp.157-190, 2014.

L. Gabry?ová, M. Alvarez-martinez, R. Luisier, L. S. Cox, J. Sodenkamp et al., c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4 + T cells, Nat. Immunol, vol.19, pp.497-507, 2018.

M. Galeazzi, L. Bazzichi, G. D. Sebastiani, D. Neri, E. Garcia et al., A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate, Isr. Med. Assoc. J, vol.16, p.666, 2014.

R. Gandhi, D. Kumar, E. J. Burns, M. Nadeau, B. Dake et al., Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells, Nat. Immunol, vol.11, pp.846-853, 2010.

M. Gao, C. Zhang, Y. Ma, L. Bu, L. Yan et al., Hydrodynamic delivery of mIL10 gene protects mice from high-fat diet-induced obesity and glucose intolerance, Mol. Ther, vol.21, pp.1852-1861, 2013.

R. T. Gazzinelli, I. P. Oswald, S. L. James, and A. Sher, IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages, J. Immunol, vol.148, pp.1792-1796, 1992.

R. T. Gazzinelli, M. Wysocka, S. Hieny, T. Scharton-kersten, A. Cheever et al., In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, 1996.

, J. Immunol, vol.157, pp.798-805

R. R. Gerner, V. Klepsch, S. Macheiner, K. Arnhard, T. E. Adolph et al., NAD metabolism fuels human and mouse intestinal inflammation, Gut, vol.67, pp.1813-1823, 2018.

E. Glasmacher, S. Agrawal, A. B. Chang, T. L. Murphy, W. Zeng et al., A genomic regulatory element that directs assembly and function of immunespecific AP-1-IRF complexes, Science, vol.338, pp.975-980, 2012.

L. E. Gleeson, F. J. Sheedy, E. M. Palsson-mcdermott, D. Triglia, S. M. O'leary et al., Cutting Edge: Mycobacterium tuberculosis Induces Aerobic Glycolysis in Human Alveolar Macrophages That Is Required for Control of Intracellular Bacillary Replication, J. Immunol, vol.196, pp.2444-2449, 2016.

E. O. Glocker, D. Kotlarz, K. Boztug, E. M. Gertz, A. A. Schäffer et al., Inflammatory bowel disease and mutations affecting the interleukin-10 receptor, N. Engl. J. Med, vol.361, pp.2033-2045, 2009.

E. O. Glocker, N. Frede, M. Perro, N. Sebire, M. Elawad et al., Infant colitis--it's in the genes, Lancet, vol.376, issue.10, pp.61008-61010, 2010.

E. O. Glocker, D. Kotlarz, C. Klein, N. Shah, B. F. Grimbacher-;-n et al., Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells, Ann. N. Y. Acad. Sci, vol.1246, pp.1625-1631, 1990.

M. Grilli, I. Barbieri, H. Basudev, R. Brusa, C. Casati et al., Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage, Eur. J. Neurosci, vol.12, pp.2265-2272, 2000.

H. Groux, M. Bigler, J. E. De-vries, and M. G. Roncarolo, Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells, J. Exp. Med, vol.184, pp.19-29, 1996.

H. Groux, M. Bigler, J. E. De-vries, and M. G. Roncarolo, Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells, J. Immunol, vol.160, pp.3188-3193, 1998.

H. Groux, F. Cottrez, M. Rouleau, S. Mauze, S. Antonenko et al., A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells, J. Immunol, vol.162, pp.1723-1729, 1999.

A. Gupta, S. Dimeloe, D. F. Richards, E. S. Chambers, C. Black et al., , 2014.

, Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma, Thorax, vol.69, pp.508-515

A. Hagenbaugh, S. Sharma, S. M. Dubinett, S. H. Wei, R. Aranda et al., Altered immune responses in interleukin 10 transgenic mice, J. Exp. Med, vol.185, pp.2101-2110, 1997.

M. Hammer, J. Mages, H. Dietrich, F. Schmitz, F. Striebel et al., Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10, Eur. J. Immunol, vol.35, pp.2991-3001, 2005.

E. G. Hong, H. J. Ko, Y. R. Cho, H. J. Kim, Z. Ma et al., Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle, Diabetes, vol.58, pp.2525-2535, 2009.

A. Howes, C. Taubert, S. Blankley, N. Spink, X. Wu et al., Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages, J. Immunol, vol.197, pp.2838-2853, 2016.

D. H. Hsu, R. De-waal-malefyt, D. F. Fiorentino, M. N. Dang, P. Vieira et al., Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1, Science, vol.250, pp.830-832, 1990.

S. Huber, N. Gagliani, E. Esplugues, W. O'connor, F. J. Huber et al., Th17 cells express interleukin-10 receptor and are controlled by Foxp3 ? and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner, Immunity, vol.34, pp.554-565, 2011.

M. Hulsmans, H. B. Sager, J. D. Roh, M. Valero-muñoz, N. E. Houstis et al., Cardiac macrophages promote diastolic dysfunction, J. Exp. Med, vol.215, pp.423-440, 2018.

C. A. Hunter, L. A. Ellis-neyes, T. Slifer, S. Kanaly, G. Grünig et al., IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi, J. Immunol, vol.158, pp.3311-3316, 1997.

L. Hussaarts, H. H. Smits, G. Schramm, A. J. Van-der-ham, G. C. Van-der-zon et al., Rapamycin and omega-1: mTOR-dependent and -independent Th2 skewing by human dendritic cells, Immunol. Cell Biol, vol.91, pp.486-489, 2013.

A. P. Hutchins, S. Poulain, and D. Miranda-saavedra, Genome-wide analysis of STAT3 binding in vivo predicts effectors of the antiinflammatory response in macrophages, Blood, vol.119, pp.110-119, 2012.

A. P. Hutchins, D. Diez, and D. Miranda-saavedra, The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges, Brief. Funct. Genomics, vol.12, pp.489-498, 2013.

A. P. Hutchins, Y. Takahashi, and D. Miranda-saavedra, Genomic analysis of LPS-stimulated myeloid cells identifies a common proinflammatory response but divergent IL-10 anti-inflammatory responses, Sci. Rep, vol.5, p.9100, 2015.

J. P. Huynh, C. C. Lin, J. M. Kimmey, N. N. Jarjour, E. A. Schwarzkopf et al., Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection, J. Exp. Med, vol.215, pp.1823-1838, 2018.

J. Hyun, L. Romero, R. Riveron, C. Flores, S. Kanagavelu et al., Human intestinal epithelial cells express interleukin-10 through Toll-like receptor 4-mediated epithelial-macrophage crosstalk, J. Innate Immun, vol.7, pp.87-101, 2015.

S. H. Im, A. Hueber, S. Monticelli, K. H. Kang, and A. Rao, Chromatinlevel regulation of the IL10 gene in T cells, J. Biol. Chem, vol.279, pp.46818-46825, 2004.

W. K. Ip, N. Hoshi, D. S. Shouval, S. Snapper, and R. Medzhitov, Antiinflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages, Science, vol.356, pp.513-519, 2017.

H. Ishii, S. Tanabe, M. Ueno, T. Kubo, H. Kayama et al., ifn-?-dependent secretion of IL-10 from Th1 cells and microglia/macrophages contributes to functional recovery after spinal cord injury, Cell Death Dis, vol.4, 2013.

E. Itakura, R. R. Huang, D. R. Wen, E. Paul, P. H. Wünsch et al., IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence, Mod. Pathol, vol.24, pp.801-809, 2011.

K. Itoh and S. Hirohata, The role of IL-10 in human B cell activation, proliferation, and differentiation, J. Immunol, vol.154, pp.4341-4350, 1995.

S. S. Iyer, T. Gensollen, A. Gandhi, S. F. Oh, J. F. Neves et al., Dietary and Microbial Oxazoles Induce Intestinal Inflammation by Modulating Aryl Hydrocarbon Receptor Responses, Cell, vol.173, pp.1123-1134, 2018.

N. N. Jarjour, E. A. Schwarzkopf, T. R. Bradstreet, I. Shchukina, C. C. Lin et al., Bhlhe40 mediates tissue-specific control of macrophage proliferation in homeostasis and type 2 immunity, Nat. Immunol, vol.20, pp.687-700, 2019.

A. Jarry, C. Bossard, C. Bou-hanna, D. Masson, E. Espaze et al., Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants, J. Clin. Invest, vol.118, pp.1132-1142, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00277246

G. Jayawardane, G. C. Russell, J. Thomson, D. Deane, H. Cox et al., A captured viral interleukin 10 gene with cellular exon structure, J. Gen. Virol, vol.89, pp.2447-2455, 2008.

E. A. Jones and R. A. Flavell, Distal enhancer elements transcribe intergenic RNA in the IL-10 family gene cluster, J. Immunol, vol.175, pp.7437-7446, 2005.

L. Jostins, S. Ripke, R. K. Weersma, R. H. Duerr, D. P. Mcgovern et al., International IBD Genetics Consortium (IIBDGC). 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, vol.491, pp.119-124

F. Kaiser, D. Cook, S. Papoutsopoulou, R. Rajsbaum, X. Wu et al., TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells, J. Exp. Med, vol.206, pp.1863-1871, 2009.

M. Kamanaka, S. Huber, L. A. Zenewicz, N. Gagliani, C. Rathinam et al., Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology, J. Exp. Med, vol.208, pp.1027-1040, 2011.

E. Kanters, M. Pasparakis, M. J. Gijbels, M. N. Vergouwe, I. Partouns-hendriks et al., Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice, J. Clin. Invest, vol.112, pp.1176-1185, 2003.

T. Kasama, R. M. Strieter, N. W. Lukacs, M. D. Burdick, and S. L. Kunkel, Regulation of neutrophil-derived chemokine expression by IL-10, 1994.

, J. Immunol, vol.152, pp.3559-3569

C. Kim, Y. Sano, K. Todorova, B. A. Carlson, L. Arpa et al., The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro-and anti-inflammatory gene expression, Nat. Immunol, vol.9, pp.1019-1027, 2008.

A. Kimura, T. Naka, T. Nakahama, I. Chinen, K. Masuda et al., Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses, J. Exp. Med, vol.206, pp.2027-2035, 2009.

A. King, S. Balaji, L. D. Le, T. M. Crombleholme, and S. G. Keswani, Regenerative Wound Healing: The Role of Interleukin-10, Adv. Wound Care, vol.3, pp.315-323, 2014.

S. M. Knoblach and A. I. Faden, Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury, Exp. Neurol, vol.153, pp.143-151, 1998.

M. Kobayashi, M. N. Kweon, H. Kuwata, R. D. Schreiber, H. Kiyono et al., Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice, J. Clin. Invest, vol.111, pp.1297-1308, 2003.

A. Kole and K. J. Maloy, Control of intestinal inflammation by interleukin-10, Curr. Top. Microbiol. Immunol, vol.380, pp.19-38, 2014.

D. J. Kominsky, E. L. Campbell, S. F. Ehrentraut, K. E. Wilson, C. J. Kelly et al., IFN-?-mediated induction of an apical IL-10 receptor on polarized intestinal epithelia, J. Immunol, vol.192, pp.1267-1276, 2014.

B. Koscsó, B. Csóka, Z. Selmeczy, L. Himer, P. Pacher et al., Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process, J. Immunol, vol.188, pp.445-453, 2012.

S. V. Kotenko, S. Saccani, L. S. Izotova, O. V. Mirochnitchenko, and S. Pestka, Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10), Proc. Natl. Acad. Sci. USA, vol.97, pp.1695-1700, 2000.

R. Kühn, J. Löhler, D. Rennick, K. Rajewsky, and W. Müller, Interleukin-10-deficient mice develop chronic enterocolitis, Cell, vol.75, pp.263-274, 1993.

H. Kuwata, Y. Watanabe, H. Miyoshi, M. Yamamoto, T. Kaisho et al., IL-10-inducible Bcl-3 negatively regulates LPSinduced TNF-alpha production in macrophages, Blood, vol.102, pp.4123-4129, 2003.

A. J. Kwilasz, P. M. Grace, P. Serbedzija, S. F. Maier, and L. R. Watkins, The therapeutic potential of interleukin-10 in neuroimmune diseases, Neuropharmacology, vol.96, pp.55-69, 2015.

R. Lang, D. Patel, J. J. Morris, R. L. Rutschman, and P. J. Murray, Shaping gene expression in activated and resting primary macrophages by IL-10, 2002.

, J. Immunol, vol.169, pp.2253-2263

R. Lang, A. L. Pauleau, E. Parganas, Y. Takahashi, J. Mages et al., SOCS3 regulates the plasticity of gp130 signaling, Nat. Immunol, vol.4, pp.546-550, 2003.

J. M. Lanis, E. E. Alexeev, V. F. Curtis, D. A. Kitzenberg, D. J. Kao et al., Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia, Mucosal Immunol, vol.10, pp.1133-1144, 2017.

F. N. Lauw, D. Pajkrt, C. E. Hack, M. Kurimoto, S. J. Van-deventer et al., Proinflammatory effects of IL-10 during human endotoxemia, J. Immunol, vol.165, pp.2783-2789, 2000.

A. Ledeboer, J. J. Brevé, A. Wierinckx, S. Van-der-jagt, A. F. Bristow et al., Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells, Eur. J. Neurosci, vol.16, pp.1175-1185, 2002.

T. S. Lee and L. Y. Chau, Heme oxygenase-1 mediates the antiinflammatory effect of interleukin-10 in mice, Nat. Med, vol.8, pp.240-246, 2002.

C. G. Lee, K. H. Kang, J. S. So, H. K. Kwon, J. S. Son et al., A distal cis-regulatory element, CNS-9, controls NFAT1 and IRF4-mediated IL-10 gene activation in T helper cells, Mol. Immunol, vol.46, pp.613-621, 2009.

J. Lehmann, D. Seegert, I. Strehlow, C. Schindler, M. L. Lohmann-matthes et al., IL-10-induced factors belonging to the p91 family of proteins bind to IFN-gamma-responsive promoter elements, J. Immunol, vol.153, pp.165-172, 1994.

C. Li, I. Corraliza, and J. Langhorne, A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice, Infect. Immun, vol.67, pp.4435-4442, 1999.

L. Li, L. Huang, H. Ye, S. P. Song, A. Bajwa et al., Dendritic cells tolerized with adenosine A 2 AR agonist attenuate acute kidney injury, J. Clin. Invest, vol.122, pp.3931-3942, 2012.

P. Li, R. Spolski, W. Liao, L. Wang, T. L. Murphy et al., BATF-JUN is critical for IRF4-mediated transcription in T cells, Nature, vol.490, pp.543-546, 2012.

C. C. Lin, T. R. Bradstreet, E. A. Schwarzkopf, J. Sim, J. A. Carrero et al., Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation, Nat. Commun, vol.5, p.3551, 2014.

F. S. Lira, J. C. Rosa, G. D. Pimentel, M. Seelaender, A. R. Damaso et al., Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-?B pathway in 3T3-L1 adipocytes, Cytokine, vol.57, pp.98-106, 2012.

Y. W. Liu, C. C. Chen, H. P. Tseng, and W. C. Chang, Lipopolysaccharideinduced transcriptional activation of interleukin-10 is mediated by MAPK-and NF-kappaB-induced CCAAT/enhancer-binding protein delta in mouse macrophages, Cell. Signal, vol.18, pp.1492-1500, 2006.

L. Llorente, Y. Richaud-patin, C. García-padilla, E. Claret, J. Jakez-ocampo et al., Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus, Arthritis Rheum, vol.43, pp.1790-1800, 2000.

D. Lobo-silva, G. M. Carriche, A. G. Castro, S. Roque, and M. Saraiva, Balancing the immune response in the brain: IL-10 and its regulation, J. Neuroinflammation, vol.13, p.297, 2016.

D. Lobo-silva, G. M. Carriche, A. G. Castro, S. Roque, and M. Saraiva, Interferon-? regulates the production of IL-10 by toll-like receptoractivated microglia, Glia, vol.65, pp.1439-1451, 2017.

V. Lorén, E. Cabré, I. Ojanguren, E. Domènech, E. Pedrosa et al., Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative Colitis, PLoS One, vol.10, p.130921, 2015.

K. Loser, J. Apelt, M. Voskort, M. Mohaupt, S. Balkow et al., IL-10 controls ultraviolet-induced carcinogenesis in mice, J. Immunol, vol.179, pp.365-371, 2007.

C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, Obesity induces a phenotypic switch in adipose tissue macrophage polarization, J. Clin. Invest, vol.117, pp.175-184, 2007.

M. Luu, S. Pautz, V. Kohl, R. Singh, R. Romero et al., The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes, Nat. Commun, vol.10, p.760, 2019.

S. E. Macatonia, T. M. Doherty, S. C. Knight, and A. O'garra, Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFNgamma production, J. Immunol, vol.150, pp.3755-3765, 1993.

I. A. Macneil, T. Suda, K. W. Moore, T. R. Mosmann, and A. Zlotnik, IL-10, a novel growth cofactor for mature and immature T cells, J. Immunol, vol.145, pp.4167-4173, 1990.

E. H. Mann, L. Gabry?ová, P. E. Pfeffer, A. O'garra, and C. M. Hawrylowicz, High-Dose IL-2 Skews a Glucocorticoid-Driven IL-17 + IL-10 + Memory CD4 + T Cell Response towards a Single IL-10-Producing Phenotype, J. Immunol, vol.202, pp.684-693, 2019.

M. H. Mannino, Z. Zhu, H. Xiao, Q. Bai, M. R. Wakefield et al., The paradoxical role of IL-10 in immunity and cancer, Cancer Lett, vol.367, pp.103-107, 2015.

S. Márquez, J. J. Fernández, C. Mancebo, C. Herrero-sánchez, S. Alonso et al., Tricarboxylic Acid Cycle Activity and Remodeling of Glycerophosphocholine Lipids Support Cytokine Induction in Response to Fungal Patterns, Cell Reports, vol.27, pp.525-536, 2019.

M. Martin, R. E. Schifferle, N. Cuesta, S. N. Vogel, J. Katz et al., Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide, J. Immunol, vol.171, pp.717-725, 2003.

I. D. Mascanfroni, M. C. Takenaka, A. Yeste, B. Patel, Y. Wu et al., Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-?, Nat. Med, vol.21, pp.638-646, 2015.

A. Matsukawa, K. Takeda, S. Kudo, T. Maeda, M. Kagayama et al., Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils, J. Immunol, vol.171, pp.6198-6205, 2003.

A. Matsukawa, S. Kudo, T. Maeda, K. Numata, H. Watanabe et al., Stat3 in resident macrophages as a repressor protein of inflammatory response, J. Immunol, vol.175, pp.3354-3359, 2005.

J. Mauer, B. Chaurasia, J. Goldau, M. C. Vogt, J. Ruud et al., Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin, Nat. Immunol, vol.15, pp.423-430, 2014.

A. Mauras, F. Chain, A. Faucheux, P. Ruffié, S. Gontier et al., A New Bifidobacteria Expression SysTem (BEST) to Produce and Deliver Interleukin-10 in Bifidobacterium bifidum, Front. Microbiol, vol.9, p.3075, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02126568

C. E. Mccoy, F. J. Sheedy, J. E. Qualls, S. L. Doyle, S. R. Quinn et al., IL-10 inhibits miR-155 induction by toll-like receptors, J. Biol. Chem, vol.285, pp.20492-20498, 2010.

I. B. Mcinnes, G. G. Illei, C. L. Danning, C. H. Yarboro, M. Crane et al., IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis, J. Immunol, vol.167, pp.4075-4082, 2001.

F. W. Mcnab, J. Ewbank, A. Howes, L. Moreira-teixeira, A. Martirosyan et al., Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-? for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages, J. Immunol, vol.193, pp.3600-3612, 2014.

A. R. Mesquita, M. Correia-neves, S. Roque, A. G. Castro, P. Vieira et al., IL-10 modulates depressive-like behavior, J. Psychiatr. Res, vol.43, pp.89-97, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-00455431

A. M. Miller, H. Wang, A. Bertola, O. Park, N. Horiguchi et al., Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice, Hepatology, vol.54, pp.846-856, 2011.

E. Molina-holgado, J. M. Vela, A. Arévalo-martín, and C. Guaza, LPS/ IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10, Eur. J. Neurosci, vol.13, pp.493-502, 2001.

K. W. Moore, P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan et al., Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI, Science, vol.248, pp.1230-1234, 1990.

K. W. Moore, R. De-waal-malefyt, R. L. Coffman, and A. O'garra, Interleukin-10 and the interleukin-10 receptor, Annu. Rev. Immunol, vol.19, pp.683-765, 2001.

C. J. Moran, T. D. Walters, C. H. Guo, S. Kugathasan, C. Klein et al., IL-10R polymorphisms are associated with very-early-onset ulcerative colitis, Inflamm. Bowel Dis, vol.19, pp.115-123, 2013.

J. B. Mumm, J. Emmerich, X. Zhang, I. Chan, L. Wu et al., IL-10 elicits IFN?-dependent tumor immune surveillance, Cancer Cell, vol.20, pp.781-796, 2011.

M. Murai, O. Turovskaya, G. Kim, R. Madan, C. L. Karp et al., Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis, Nat. Immunol, vol.10, pp.1178-1184, 2009.

P. J. Murray, The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription, Proc. Natl. Acad. Sci. USA, vol.102, pp.8686-8691, 2005.

P. J. Murray, STAT3-mediated anti-inflammatory signalling, Biochem. Soc. Trans, vol.34, pp.1028-1031, 2006.

P. J. Murray, Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response, Curr. Opin. Pharmacol, vol.6, pp.379-386, 2006.

P. J. Murray, The JAK-STAT signaling pathway: input and output integration, J. Immunol, vol.178, pp.2623-2629, 2007.

H. W. Murray, C. M. Lu, S. Mauze, S. Freeman, A. L. Moreira et al., Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy, Infect. Immun, vol.70, pp.6284-6293, 2002.

A. Naing, K. P. Papadopoulos, K. A. Autio, P. A. Ott, M. R. Patel et al., Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors, 2016.

, J. Clin. Oncol, vol.34, pp.3562-3569

A. Naing, J. R. Infante, K. P. Papadopoulos, I. H. Chan, C. Shen et al., PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8 + T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients, Cancer Cell, vol.34, pp.775-791, 2018.

D. Nandan, C. Camargo-de-oliveira, A. Moeenrezakhanlou, M. Lopez, J. M. Silverman et al., Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3? downstream of phosphatidylinositol-3 kinase, J. Immunol, vol.188, pp.367-378, 2012.

A. Nasi, T. Fekete, A. Krishnamurthy, S. Snowden, E. Rajnavölgyi et al., Dendritic cell reprogramming by endogenously produced lactic acid, J. Immunol, vol.191, pp.3090-3099, 2013.

D. R. Nelson, G. Y. Lauwers, J. Y. Lau, and G. L. Davis, Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders, Gastroenterology, vol.118, pp.655-660, 2000.

J. Nemunaitis, T. Fong, P. Shabe, D. Martineau, and D. Ando, Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma, Cancer Invest, vol.19, pp.239-247, 2001.

C. Neumann, F. Heinrich, K. Neumann, V. Junghans, M. F. Mashreghi et al., Role of Blimp-1 in programing Th effector cells into IL-10 producers, J. Exp. Med, vol.211, pp.1807-1819, 2014.

D. M. Norden, A. M. Fenn, A. Dugan, and J. P. Godbout, TGF? produced by IL-10 redirected astrocytes attenuates microglial activation, Glia, vol.62, pp.881-895, 2014.

A. O'garra, F. J. Barrat, A. G. Castro, A. Vicari, C. Hawrylowicz et al., Strategies for use of IL-10 or its antagonists in human disease, Immunol. Rev, vol.223, pp.15-23, 2008.

M. Ohtani, S. Nagai, S. Kondo, S. Mizuno, K. Nakamura et al., Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells, Blood, vol.112, pp.635-643, 2008.

T. Olszak, J. F. Neves, C. M. Dowds, K. Baker, J. Glickman et al., Protective mucosal immunity mediated by epithelial CD1d and IL-10, Nature, vol.509, pp.497-502, 2014.

W. Ouyang and A. O'garra, IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation, Immunity, vol.50, pp.871-891, 2019.

W. Ouyang, S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz, Regulation and functions of the IL-10 family of cytokines in inflammation and disease, Annu. Rev. Immunol, vol.29, pp.71-109, 2011.

E. M. Palsson-mcdermott, A. M. Curtis, G. Goel, M. A. Lauterbach, F. J. Sheedy et al., Pyruvate Kinase M2 Regulates Hif-1? Activity and IL-1? Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages, Cell Metab, vol.21, p.347, 2015.

L. Pereira, M. Font-nieves, C. Van-den-haute, V. Baekelandt, A. M. Planas et al., IL-10 regulates adult neurogenesis by modulating ERK and STAT3 activity, Front. Cell. Neurosci, vol.9, p.57, 2015.

F. J. Perez-asensio, U. Perpiñá, A. M. Planas, and E. Pozas, Interleukin-10 regulates progenitor differentiation and modulates neurogenesis in adult brain, J. Cell Sci, vol.126, pp.4208-4219, 2013.

G. Perriard, A. Mathias, L. Enz, M. Canales, M. Schluep et al., Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes, J. Neuroinflammation, vol.12, p.119, 2015.

E. Perucha, R. Melchiotti, J. A. Bibby, W. Wu, K. S. Frederiksen et al., The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells, Nat. Commun, vol.10, p.498, 2019.

S. Pestka, C. D. Krause, D. Sarkar, M. R. Walter, Y. Shi et al., Interleukin-10 and related cytokines and receptors, Annu. Rev. Immunol, vol.22, pp.929-979, 2004.

C. Pot, H. Jin, A. Awasthi, S. M. Liu, C. Y. Lai et al., Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells, J. Immunol, vol.183, pp.797-801, 2009.

M. Quiros, H. Nishio, P. A. Neumann, D. Siuda, J. C. Brazil et al., Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling, J. Clin. Invest, vol.127, pp.3510-3520, 2017.

A. A. Rahimi, K. Gee, S. Mishra, W. Lim, and A. Kumar, STAT-1 mediates the stimulatory effect of IL-10 on CD14 expression in human monocytic cells, J. Immunol, vol.174, pp.7823-7832, 2005.

P. Rajbhandari, B. J. Thomas, A. C. Feng, C. Hong, J. Wang et al., IL-10 Signaling Remodels Adipose Chromatin Architecture to Limit Thermogenesis and Energy Expenditure, Cell, vol.172, pp.218-233, 2018.

P. S. Redford, A. Boonstra, S. Read, J. Pitt, C. Graham et al., Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung, Eur. J. Immunol, vol.40, pp.2200-2210, 2010.

P. S. Redford, P. J. Murray, and A. O'garra, The role of IL-10 in immune regulation during M. tuberculosis infection, vol.4, pp.261-270, 2011.

D. F. Richards, M. Fernandez, J. Caulfield, and C. M. Hawrylowicz, Glucocorticoids drive human CD8(+) T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production, Eur. J. Immunol, vol.30, pp.2344-2354, 2000.

J. K. Riley, K. Takeda, S. Akira, and R. D. Schreiber, Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action, J. Biol. Chem, vol.274, pp.16513-16521, 1999.

S. J. Rodig, M. A. Meraz, J. M. White, P. A. Lampe, J. K. Riley et al., Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses, Cell, vol.93, pp.81166-81172, 1998.

F. Rousset, E. Garcia, T. Defrance, C. Péronne, N. Vezzio et al., Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes, 1992.

, Proc. Natl. Acad. Sci. USA, vol.89, pp.1890-1893

B. Ruffell, D. Chang-strachan, V. Chan, A. Rosenbusch, C. M. Ho et al., Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells, Cancer Cell, vol.26, pp.623-637, 2014.

S. Rutz and W. Ouyang, Regulation of Interleukin-10 Expression, Adv. Exp. Med. Biol, vol.941, pp.89-116, 2016.

M. Saraiva and A. O'garra, The regulation of IL-10 production by immune cells, Nat. Rev. Immunol, vol.10, pp.170-181, 2010.

M. Saraiva, J. R. Christensen, A. V. Tsytsykova, A. E. Goldfeld, S. C. Ley et al., Identification of a macrophage-specific chromatin signature in the IL-10 locus, J. Immunol, vol.175, pp.1041-1046, 2005.

M. Saraiva, J. R. Christensen, M. Veldhoen, T. L. Murphy, K. M. Murphy et al., Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose, Immunity, vol.31, pp.209-219, 2009.

D. V. Sawant, H. Yano, M. Chikina, Q. Zhang, M. Liao et al., Adaptive plasticity of IL-10 + and IL-35 + T reg cells cooperatively promotes tumor T cell exhaustion, Nat. Immunol, vol.20, pp.724-735, 2019.

B. Schaljo, F. Kratochvill, N. Gratz, I. Sadzak, I. Sauer et al., Tristetraprolin is required for full anti-inflammatory response of murine macrophages to IL-10, J. Immunol, vol.183, pp.1197-1206, 2009.

S. Schreiber, R. N. Fedorak, O. H. Nielsen, G. Wild, C. N. Williams et al., Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group, Gastroenterology, vol.119, pp.1461-1472, 2000.

D. R. Seo, K. Y. Kim, and Y. B. Lee, Interleukin-10 expression in lipopolysaccharide-activated microglia is mediated by extracellular ATP in an autocrine fashion, Neuroreport, vol.15, pp.1157-1161, 2004.

D. R. Seo, S. Y. Kim, K. Y. Kim, H. G. Lee, J. H. Moon et al., Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells, Exp. Mol. Med, vol.40, pp.19-26, 2008.

S. Shigemori and T. Shimosato, Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of, Inflammatory Bowel Diseases. Front. Immunol, vol.8, p.22, 2017.

J. Shoemaker, M. Saraiva, and A. O'garra, GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+ T cells, J. Immunol, vol.176, pp.3470-3479, 2006.

D. S. Shouval, A. Biswas, J. A. Goettel, K. Mccann, E. Conaway et al., Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function, Immunity, vol.40, pp.706-719, 2014.

D. S. Shouval, J. Ouahed, A. Biswas, J. A. Goettel, B. H. Horwitz et al., Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans, Adv. Immunol, vol.122, pp.177-210, 2014.

N. Singh, A. Gurav, S. Sivaprakasam, E. Brady, R. Padia et al., Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis, Immunity, vol.40, pp.128-139, 2014.

A. M. Smith, J. E. Qualls, K. O'brien, L. Balouzian, P. F. Johnson et al., A distal enhancer in Il12b is the target of transcriptional repression by the STAT3 pathway and requires the basic leucine zipper (B-ZIP) protein NFIL3, J. Biol. Chem, vol.286, p.23582, 2011.

L. Steidler, W. Hans, L. Schotte, S. Neirynck, F. Obermeier et al., Treatment of murine colitis by Lactococcus lactis secreting interleukin-10, Science, vol.289, pp.1352-1355, 2000.

J. S. Stumhofer, J. S. Silver, A. Laurence, P. M. Porrett, T. H. Harris et al., Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10, Nat. Immunol, vol.8, pp.1363-1371, 2007.

J. Sun, H. Dodd, E. K. Moser, R. Sharma, and T. J. Braciale, CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs, Nat. Immunol, vol.12, pp.327-334, 2011.

M. Sun, W. Wu, L. Chen, W. Yang, X. Huang et al., Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis, Nat. Commun, vol.9, p.3555, 2018.

Y. Sun, M. Iyer, R. Mceachin, M. Zhao, Y. M. Wu et al., Genome-Wide STAT3 Binding Analysis after Histone Deacetylase Inhibition Reveals Novel Target Genes in Dendritic Cells, J. Innate Immun, vol.9, pp.126-144, 2017.

E. Sziksz, D. Pap, R. Lippai, N. J. Béres, A. Fekete et al., Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family. Mediators Inflamm, p.764641, 2015.

K. Takeda, B. E. Clausen, T. Kaisho, T. Tsujimura, N. Terada et al., Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity, vol.10, pp.80005-80014, 1999.

P. H. Tan, H. E. Tyrrell, L. Gao, D. Xu, J. Quan et al., Adiponectin receptor signaling on dendritic cells blunts antitumor immunity, Cancer Res, vol.74, pp.5711-5722, 2014.

C. Tanchot, S. Guillaume, J. Delon, C. Bourgeois, A. Franzke et al., Modifications of CD8+ T cell function during in vivo memory or tolerance induction, Immunity, vol.8, pp.581-590, 1998.

L. Thompson-snipes, V. Dhar, M. W. Bond, T. R. Mosmann, K. W. Moore et al., Interleukin 10: a novel stimulatory factor for mast cells and their progenitors, J. Exp. Med, vol.173, pp.507-510, 1991.

H. Tilg, H. Ulmer, A. Kaser, and G. Weiss, Role of IL-10 for induction of anemia during inflammation, J. Immunol, vol.169, pp.2204-2209, 2002.

H. Tilg, C. Van-montfrans, A. Van-den-ende, A. Kaser, S. J. Van-deventer et al., Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma, Gut, vol.50, pp.191-195, 2002.

E. Trachsel, F. Bootz, M. Silacci, M. Kaspar, H. Kosmehl et al., Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis, Arthritis Res. Ther, vol.9, 2007.

R. Upadhyay, A. Sanchez-hidalgo, C. J. Wilusz, A. J. Lenaerts, J. Arab et al., Host Directed Therapy for Chronic Tuberculosis via Intrapulmonary Delivery of Aerosolized Peptide Inhibitors Targeting the IL-10-STAT3 Pathway, Sci. Rep, vol.8, p.16610, 2018.

S. J. Van-deventer, C. O. Elson, and R. N. Fedorak, Multiple doses of intravenous interleukin 10 in steroidrefractory Crohn's disease, Gastroenterology, vol.113, pp.383-389, 1997.

E. Van-exel, J. Gussekloo, A. J. De-craen, M. Frölich, A. Bootsma-van-der-wiel et al., Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study, Diabetes, vol.51, pp.1088-1092, 2002.

R. Verma, L. Balakrishnan, K. Sharma, A. A. Khan, J. Advani et al., A network map of Interleukin-10 signaling pathway, J. Cell Commun. Signal, vol.10, pp.61-67, 2016.

C. Veroni, L. Gabriele, I. Canini, L. Castiello, E. Coccia et al., Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways, Mol. Cell. Neurosci, vol.45, pp.234-244, 2010.

A. P. Vicari, C. Chiodoni, C. Vaure, S. Aït-yahia, C. Dercamp et al., Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody, J. Exp. Med, vol.196, pp.541-549, 2002.

P. M. Vidal, E. Lemmens, D. Dooley, and S. Hendrix, The role of "antiinflammatory" cytokines in axon regeneration, Cytokine Growth Factor Rev, vol.24, pp.1-12, 2013.

P. Vieira, R. De-waal-malefyt, M. N. Dang, K. E. Johnson, R. Kastelein et al., Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI, Proc. Natl. Acad. Sci. USA, vol.88, pp.1172-1176, 1991.

S. Vigne, F. Chalmin, D. Duc, A. S. Clottu, L. Apetoh et al., IL-27-Induced Type 1 Regulatory T-Cells Produce Oxysterols that Constrain IL-10 Production. Front. Immunol, vol.8, p.1184, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01624281

I. Vouldoukis, P. A. Bécherel, V. Riveros-moreno, M. Arock, O. Silva et al., Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation, Eur. J. Immunol, vol.27, pp.860-865, 1997.

X. Wang, K. Wong, W. Ouyang, and S. Rutz, Targeting IL-10 Family Cytokines for the Treatment of Human Diseases, 2019.

, Perspect. Biol, vol.11, 28548.

Z. Y. Wang, H. Sato, S. Kusam, S. Sehra, L. M. Toney et al., Regulation of IL-10 gene expression in Th2 cells by, 2005.

, J. Immunol, vol.174, pp.2098-2105

B. K. Weaver, E. Bohn, B. A. Judd, M. P. Gil, and R. D. Schreiber, ABIN-3: a molecular basis for species divergence in interleukin-10-induced antiinflammatory actions, Mol. Cell. Biol, vol.27, pp.4603-4616, 2007.

R. M. Weber-nordt, J. K. Riley, A. C. Greenlund, K. W. Moore, J. E. Darnell et al., Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain, J. Biol. Chem, vol.271, pp.27954-27961, 1996.

J. Wehinger, F. Gouilleux, B. Groner, J. Finke, R. Mertelsmann et al., IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes, FEBS Lett, vol.394, pp.365-370, 1996.

T. Weichhart, G. Costantino, M. Poglitsch, M. Rosner, M. Zeyda et al., The TSC-mTOR signaling pathway regulates the innate inflammatory response, Immunity, vol.29, pp.565-577, 2008.

E. L. Werry, G. J. Liu, M. D. Lovelace, R. Nagarajah, I. B. Hickie et al., Lipopolysaccharide-stimulated interleukin-10 release from neonatal spinal cord microglia is potentiated by glutamate. Neuroscience, vol.175, pp.93-103, 2011.

F. Willems, A. Marchant, J. P. Delville, C. Gérard, A. Delvaux et al., Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes, Eur. J. Immunol, vol.24, pp.1007-1009, 1994.

L. Williams, L. Bradley, A. Smith, and B. Foxwell, Signal transducer and activator of transcription 3 is the dominant mediator of the antiinflammatory effects of IL-10 in human macrophages, J. Immunol, vol.172, pp.567-576, 2004.

L. M. Williams, G. Ricchetti, U. Sarma, T. Smallie, and B. M. Foxwell, Interleukin-10 suppression of myeloid cell activation--a continuing puzzle, Immunology, vol.113, pp.281-292, 2004.

L. Xie, Q. Fu, T. M. Ortega, L. Zhou, D. Rasmussen et al., Overexpression of IL-10 in C2D macrophages promotes a macrophage phenotypic switch in adipose tissue environments, PLoS One, vol.9, 2014.

J. Xin, D. A. Wainwright, N. A. Mesnard, C. J. Serpe, V. M. Sanders et al., IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection, Brain Behav. Immun, vol.25, pp.820-829, 2011.

J. Xu, Y. Yang, G. Qiu, G. Lal, Z. Wu et al., c-Maf regulates IL-10 expression during Th17 polarization, J. Immunol, vol.182, pp.6226-6236, 2009.

E. Xystrakis, S. Kusumakar, S. Boswell, E. Peek, Z. Urry et al., Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoidresistant asthma patients, J. Clin. Invest, vol.116, pp.146-155, 2006.

A. K. Yi, J. G. Yoon, S. J. Yeo, S. C. Hong, B. K. English et al., Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response, J. Immunol, vol.168, p.4711, 2002.

S. I. Yoon, N. J. Logsdon, F. Sheikh, R. P. Donnelly, and M. R. Walter, Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex, J. Biol. Chem, vol.281, pp.35088-35096, 2006.

H. Yssel, R. De-waal-malefyt, M. G. Roncarolo, J. S. Abrams, R. Lahesmaa et al., IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells, J. Immunol, vol.149, pp.2378-2384, 1992.

F. Yu, S. Sharma, D. Jankovic, R. K. Gurram, P. Su et al., The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination, J. Exp. Med, vol.215, pp.1813-1821, 2018.

A. Zdanov, Structural analysis of cytokines comprising the IL-10 family, Cytokine Growth Factor Rev, vol.21, pp.325-330, 2010.

P. Zhang, J. S. Lee, K. H. Gartlan, I. S. Schuster, I. Comerford et al., Eomesodermin promotes the development of type 1 regulatory T (T R 1) cells. Sci. Immunol, vol.2, p.7152, 2017.

S. Zhang, S. Weinberg, M. Deberge, A. Gainullina, M. Schipma et al., , 2019.

, Efferocytosis Fuels Requirements of Fatty Acid Oxidation and the Electron Transport Chain to Polarize Macrophages for Tissue Repair

, Cell Metab, vol.29, pp.443-456

L. M. Zheng, D. M. Ojcius, F. Garaud, C. Roth, E. Maxwell et al., Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism, J. Exp. Med, vol.184, pp.579-584, 1996.

Z. Zhou, X. Peng, R. Insolera, D. J. Fink, and M. Mata, IL-10 promotes neuronal survival following spinal cord injury, Exp. Neurol, vol.220, pp.183-190, 2009.

Z. Zhou, X. Peng, R. Insolera, D. J. Fink, and M. Mata, Interleukin-10 provides direct trophic support to neurons, J. Neurochem, vol.110, pp.1617-1627, 2009.

J. Zhu, B. Min, J. Hu-li, C. J. Watson, A. Grinberg et al., Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses, Nat. Immunol, vol.5, pp.1157-1165, 2004.

Y. P. Zhu, J. R. Brown, D. Sag, L. Zhang, and J. Suttles, Adenosine 59-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages, J. Immunol, vol.194, pp.584-594, 2015.

E. Zigmond, B. Bernshtein, G. Friedlander, C. R. Walker, S. Yona et al., Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis, Immunity, vol.40, pp.720-733, 2014.